Markets Gone Wild

Lanier Biotherapeutics Announces Issuance of U.S. Patent for IL-25 Binding Monoclonal Antibodies BOGART, Georgia, Nov. 14, 2022 (GLOBE NEWSWIRE) — Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, Type 2 inflammatory diseases, and oncology, today announced that the United States Patent and Trademark Office has issued U.S. Patent…

GWG Holdings, Inc. Announces Resignations of Murray T. Holland as President and Chief Executive Officer and Timothy L. Evans as Chief Financial Officer and Treasurer DALLAS, Nov. 14, 2022 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq: GWGH) (the “Company”), a financial services firm based in Dallas, Texas, today announced that the Company’s President and Chief…

Are You Feeling Salty About Your Investments? Don’t Let Compass Minerals International, Inc. Leave You Feeling Bitter! Stay on Top of Your Game with Glancy Prongay & Murray LLP LOS ANGELES, Nov. 14, 2022 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 20, 2022 deadline to file a…

Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2022 Financial Results Achieving Clinical and Regulatory Milestones Longeveron Inc. has achieved key clinical and regulatory milestones across its clinical pipeline. One notable accomplishment is the completion of enrollment in Longeveron’s Phase 2a trial for Alzheimer’s Disease. This milestone marks a significant step forward in the…

Welcome to the World of Palisade Bio! Financial Results and Business Update Carlsbad, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) Hey there, fellow health enthusiasts! Have you heard the latest news from Palisade Bio, Inc.? This innovative clinical stage biopharmaceutical company, traded as Nasdaq: PALI, is making waves in the world of gastrointestinal (GI) therapies. In…

Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency Introduction Lumos Pharma recently reported positive interim results from two Phase 2 trials evaluating LUM-201, a potential breakthrough in the treatment of Pediatric Growth Hormone Deficiency (PGHD). The trials have shown promising growth in pediatric…

IS Prime, a brokerage services provider, has hired Sandeep Nanuwan from NatWest into its agency execution team. He is to “focus on institutional sales to banks, hedge funds and asset managers,” IS Prime announced in a press statement shared with Finance Magnates. Nanuwan joins IS Prime, which is a subsidiary of the ISAM Capital Markets…

The Impact of Mishandled Transactions on Crypto Exchanges Introduction Over the weekend, there was a significant run on funds held in Crypto.com following the mishandling of a $400 million Ethereum transaction. This unfortunate incident comes at a time when confidence and credibility in the cryptocurrency market have already been shaken by recent events. Key Points:…